ITMCTR2100005479
Not yet recruiting
Phase 1
Clinical study on the application of extracorporeal shock wave in the treatment of early and middle stage knee osteoarthritis based on the meridian sinew theory
The Third Medical Center of Chinese People's Liberation Army General Hospital0 sitesTBD
Conditionsknee osteoarthritis
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- knee osteoarthritis
- Sponsor
- The Third Medical Center of Chinese People's Liberation Army General Hospital
- Status
- Not yet recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •(1\)The patient's diagnostic criteria were in line with the above\-mentioned western diagnostic criteria and traditional Chinese diagnostic criteria;
- •(2\)The patients were between 40 and 75 years old;
- •(3\)Patients who have not received systematic treatment recently have not taken painkillers
- •(4\)Subjects with limited joint flexion and extension activities due to traction pain at the back of the knee joint with or without other meridian sinew types
- •(5\)The subjects voluntarily participated in the study, signed the informed consent, and were willing to cooperate in filling in relevant data and receiving follow\-up visits.
Exclusion Criteria
- •(1\)Patients with Kellgren\-Lawrence grade IV radiographic manifestations, significant narrowing of joint space and subchondral sclerosis;
- •(2\)Subjects who had received arthroscopic surgery or open surgery for the previously diseased knee;
- •(3\)Patients with other rheumatic immune diseases, such as rheumatoid arthritis, systemic lupus erythematosus, psoriatic arthritis, ankylosing spondylitis, etc
- •(4\)Patients with secondary knee OA, such as acute and chronic knee infection, tumor, tuberculosis, hematological and traumatic diseases
- •(5\)Patients with severe knee deformity, varus \> 10°, varus \> 20°, and complete loss of joint space are not suitable for conservative treatment
- •(6\)Patients with serious primary cardiovascular disease, lung disease, metabolic disease, endocrine disease, abnormal coagulation mechanism or other serious diseases affecting survival
- •(7\)In the last 3 months, the patient received acetaminophen, chondrotrophic drugs, articular cavity injection drugs and other related treatments
- •(8\)Patients who cannot cooperate with MRI examination and have contraindications for MRI examination;
- •(9\)Patients with contraindications of extracorporeal shock wave therapy;
- •(10\)Pregnant or lactating women;
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 2
Study the effects of lithotripsy in renal cyst formatioCondition 1: Renal Stone. Condition 2: Renal Cyst.Calculus of kidneyCyst of kidney, acquiredIRCT201607179904N2Vice Chancellor for research of Tabriz University of Medical Sciences60
Completed
Not Applicable
Extracorporeal shock wave therapy (ESWT) and kinesiotherapy (KIN) on women with bilateral knee osteoarthritisknee painosteoarthritisMusculoskeletal - OsteoarthritisPhysical Medicine / Rehabilitation - PhysiotherapyACTRN12616000589482Holycross College60
Active, not recruiting
Phase 1
A clinical study in patients with moderate to severe graft-versus-host disease, patients randomly assigned to standard of care or to standard of care plus Extracorporeal (ECP) Therapy with UVADEX™EUCTR2010-022780-35-HUTHERAKOS, Inc.60
Active, not recruiting
Not Applicable
A clinical study in patients with moderate to severe graft-versus-host disease, patients randomly assigned to standard of care or to standard of care plus Extracorporeal (ECP) Therapy with UVADEX™Chronic graft-versus-host disease (cGvHD)MedDRA version: 14.1Level: PTClassification code 10018651Term: Graft versus host diseaseSystem Organ Class: 10021428 - Immune system disordersTherapeutic area: Diseases [C] - Immune System Diseases [C20]EUCTR2010-022780-35-ITTHERAKOS60
Active, not recruiting
Phase 1
A clinical study in patients with moderate to severe graft-versus-host disease, patients randomly assigned to standard of care or to standard of care plus Extracorporeal (ECP) Therapy with UVADEX™Chronic graft-versus-host disease (cGvHD)MedDRA version: 14.1 Level: PT Classification code 10018651 Term: Graft versus host disease System Organ Class: 10021428 - Immune system disordersTherapeutic area: Diseases [C] - Immune System Diseases [C20]EUCTR2010-022780-35-GBTHERAKOS, Inc.60